Coastal Investment Advisors, Inc. Corbus Pharmaceuticals Holdings, Inc. Transaction History

Coastal Investment Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 12, 2021	SELL	$1.27 - $3.42 $12,700 - $34,200	-10,000 Closed	0 $0
Q4 2020 Jan 13, 2021	BUY	$0.94 - $1.89 $9,400 - $18,900	10,000 New	10,000 $13,000
Q1 2020 Apr 23, 2020	SELL	$3.44 - $7.21 $5,160 - $10,815	-1,500 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$6.6 - $7.8 $9,900 - $11,700	1,500 New	1,500 $10,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.